ADM Archer-Daniels-Midland Company

ADM Elects Directors at Annual Meeting, Declares Cash Dividend

Archer Daniels Midland Company (NYSE: ADM) today announced at its 94th Annual Stockholders’ Meeting the election of its board of directors, including new director Suzan F. Harrison.

Harrison, a 33-year veteran of Colgate-Palmolive, currently is president of Global Oral Care and has served in several senior level positions at Colgate-Palmolive, including as president of Hill’s Pet Nutrition Inc. North America.

Ten incumbent directors were also re-elected, including: Alan L. Boeckmann, Terrell K. Crews, Pierre Dufour, Donald E. Felsinger, Juan R. Luciano, Patrick J. Moore, Francisco J. Sanchez, Debra A. Sandler, Daniel T. Shih and Kelvin R. Westbrook.

Cash Dividend Declared

In addition, ADM’s Board of Directors declared a cash dividend of 32 cents per share on the company’s common stock payable June 8, 2017, to shareholders of record on May 18, 2017. This is ADM’s 342nd consecutive quarterly payment, a record of 85 years of uninterrupted dividends. As of March 31, 2017, there were 568,805,098 shares of ADM common stock outstanding.

About ADM

For more than a century, the people of Archer Daniels Midland Company (NYSE: ADM) have transformed crops into products that serve the vital needs of a growing world. Today, we’re one of the world’s largest agricultural processors and food ingredient providers, with approximately 32,000 employees serving customers in more than 160 countries. With a global value chain that includes approximately 500 crop procurement locations, 250 ingredient manufacturing facilities, 38 innovation centers and the world’s premier crop transportation network, we connect the harvest to the home, making products for food, animal feed, industrial and energy uses. Learn more at www.adm.com.

EN
04/05/2017

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Archer-Daniels-Midland Company

MarketLine Department
  • MarketLine Department

Tate & Lyle PLC - Mergers & Acquisitions (M&A), Partnerships & Allianc...

Summary Marketline's Tate & Lyle PLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Tate & Lyle PLC - Mergers & Acquisitions (M&A), Partnerships & Alliances since January2007. Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments rep...

Archer-Daniels-Midland Company: Key facts and statistics - LTM June 20...

A summary company profile, detailing Archer-Daniels-Midland Company’s business operations and financial highlights.

MarketLine Department
  • MarketLine Department

CP Kelco US Inc - Company Profile and SWOT Analysis

Summary CP Kelco US Inc - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights CP Kelco US Inc (CP Kelco), a subsidiary of J.M. Huber Corp, is a manufacturer and marketer of specialty hydrocolloids. The company primarily offers carageenan, cellulose gums, diutan gums, gellan gums,...

Archer-Daniels-Midland Company: Update following A2 confirmation

Our credit view of this issuer reflects the essential nature of the company's products, offset by its increased number of large global competitors.

MarketLine Department
  • MarketLine Department

Yifan Pharmaceutical Co Ltd - Company Profile and SWOT Analysis

Summary Yifan Pharmaceutical Co Ltd - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights Yifan Pharmaceutical Co Ltd (Yifan) develops, manufactures, markets active pharmaceutical ingredients (API), medical products and polymer materials. The company's products include Chinese tr...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch